In hypertensive patients with chronic cerebral ischemia, cerebrolysin with mexidol produced the least erythrocyte lipid profile correction among the reported regimens.
In plain wordsIn hypertensive patients with cerebral ischemia, cerebrolysin with mexidol corrected red cell membrane lipids less than the other reported regimens.
- Peptide
- Cerebrolysin
- Outcome
- DecreaseErythrocyte membrane lipid profile correction
- Study
n: not reported in source
- Comparator
- Actovegin with cereton and emoxypine with piracetam
- Outcome group
- Lipids · Cardiovascular
Source sentences
while the minimum ef- fect was produced by a combination of cerebrolysin (2152 mg concentrated complex of peptides from pig brain, intravenous drip in 100.0 mL of 0.9% sodium chloride solution) and mexidol (250 mg of 2-ethyl-6-methyl-3-hydroxypyridine succinate intravenous bolus).
1 context sentence(design, population, supporting numbers)
The combination of emoxypine (40 mg of 3-hydroxy-6-methyl-2-ethylpyridine, intramuscularly) and piracetam (1000 mg of 2-oxo-I-pyrrolidine-acetamide intravenous bolus) gave intermediate results.
In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.